Home > News > QDC announced the appointment of George Dunbar
April 20th, 2004
QDC announced the appointment of George Dunbar
Dunbarís experience includes more than 25 years as CEO, director, and senior manager with many private and public bioscience companies. Most recently he worked with investors as CEO to sell Targesome, an early-stage targeted drug delivery start-up. Prior to Targesome, Dunbar was CEO of Epic Therapeutics, a controlled release formulation company sold to Baxter Healthcare in 2002.
Steve Janack to Join Behan Communications and Lead Firmís New Innovation Practice Group December 7th, 2013
Praveen Kumar Gorakavi joins TechScout.com as Innovation Director for India &Southeast Asia December 3rd, 2013
Phasefocus Strengthens Board with New Chairman and Directors November 12th, 2013
Oliver Kraft Is Elected President of the Materials Research Society October 31st, 2013